Hugh Maddox, MD
Pain Medicine · Anniston, ALNPI 1073590170
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,531 of the $10,031 with a category attached, or 65.1%. 25 manufacturers reported payments, led by Currax Pharmaceuticals LLC at 36.9% of the total. Reporting peaked in 2020 at $4,279 and has fallen 85.8% since, to $606 in 2025. Among pain medicine clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $33.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Currax Pharmaceuticals LLC$4K
- Boston Scientific$3K
- AbbVie$1K
- Pfizer$317
- Pernix Therapeutics Holdings, Inc.$242
- Idorsia Pharmaceuticals US Inc$232
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,50035%
- Food & beverage$6,53165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Currax Pharmaceuticals LLC | 6 | $3,697 |
| Boston Scientific | 145 | $2,765 |
| AbbVie | 65 | $1,474 |
| Pfizer | 17 | $317 |
| Pernix Therapeutics Holdings, Inc. | 5 | $242 |
| Idorsia Pharmaceuticals US Inc | 13 | $232 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $173 |
| Daiichi Sankyo Inc. | 4 | $173 |
| Hikma Pharmaceuticals USA | 8 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $142 |
| Almatica Pharma LLC | 5 | $126 |
| Biodelivery Sciences International, Inc. | 2 | $90 |
| Amgen | 4 | $66 |
| Lilly USA, LLC | 3 | $64 |
| Arbor Pharmaceuticals, Inc. | 4 | $64 |
| Scilex Pharmaceuticals Inc. | 2 | $46 |
| Abbott | 2 | $41 |
| Forte Bio-pharma LLC | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $24 |
| Nalpropion Pharmaceuticals LLC | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOHYDRO ER$3,500
- SPECTRA WAVEWRITER$246
- Morphabond ER$125
- WaveWriter Alpha Prime 16$121
How this compares
$10,031 in reported general payments places this provider in the 90th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,762 | $64,892 |
| Nurtec OdtRimegepant Sulfate | 34 | $46,140 |
| QuliptaAtogepant | 14 | $15,787 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 472 | $14,236 |
| Gabapentin | 1,235 | $13,591 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 109 | $13,415 |
| Lidocaine | 97 | $10,653 |
| NeuproRotigotine | 11 | $8,725 |
| Ropinirole Hcl | 811 | $7,296 |
| Morphine Sulfate ErMorphine Sulfate | 226 | $6,316 |
| Hydroxyzine Pamoate | 598 | $4,969 |
| Diclofenac Sodium | 99 | $4,930 |
| Duloxetine Hcl | 279 | $4,497 |
| Tizanidine Hcl | 376 | $4,306 |
| Pregabalin | 228 | $4,131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $317 | $46,14034 claims |
| AbbVieQulipta | $1,474 | $15,78714 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $161 | $13,415109 claims |
| Almatica Pharma LLCSertraline Hcl | $126 | $13020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 77 pain medicine providers in Alabama.
Other pain medicine in Anniston
- Christopher PaulBirmingham$64K
- Michael CosgroveHuntsville$25K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- James ThackerHuntsville$13K
- Grant StoneMobile$11K
- Hayden HundleyDothan$11K
- Jeremy BarlowVestavia Hills$9K
- Nitin ChhabraHoover$9K
- Casey LongMontgomery$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.